Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 1995 June; 58(6): 753–755.
PMCID: PMC1073563

Prescribing of potentially harmful drugs to patients admitted to hospital after head injury.


Fundamental studies in laboratory animals show that certain drugs influence behavioural recovery after brain injury. Although some drugs have the potential to enhance recovery, others may be detrimental. The purpose of the present study was to determine how often these potentially detrimental drugs are used in the management of patients with traumatic brain injury. The medical records of 100 patients with head trauma admitted to a university hospital during one year were reviewed and the frequencies of medication prescriptions during the stay in hospital were recorded. Only 14% of patients with head injury were taking medications at the time of injury. All of the patients were prescribed medications during their stay in hospital. Seventy two per cent of the patients received one or a combination of the drugs (neuroleptics and other central dopamine receptor antagonists, benzodiazepines, and the anticonvulsants phenytoin and phenobarbitone) that animal studies suggest may impair recovery. Until the true impact of these classes of drugs on the recovery process is better understood, care should be exercised in their use.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (647K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Rimel RW, Giordani B, Barth JT, Jane JA. Moderate head injury: completing the clinical spectrum of brain trauma. Neurosurgery. 1982 Sep;11(3):344–351. [PubMed]
  • Feeney DM, Sutton RL. Pharmacotherapy for recovery of function after brain injury. Crit Rev Neurobiol. 1987;3(2):135–197. [PubMed]
  • Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast. 1993 Jul-Sep;4(3):175–192. [PMC free article] [PubMed]
  • Feeney DM, Gonzalez A, Law WA. Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science. 1982 Aug 27;217(4562):855–857. [PubMed]
  • Goldstein LB, Davis JN. Clonidine impairs recovery of beam-walking after a sensorimotor cortex lesion in the rat. Brain Res. 1990 Feb 5;508(2):305–309. [PubMed]
  • Schallert T, Hernandez TD, Barth TM. Recovery of function after brain damage: severe and chronic disruption by diazepam. Brain Res. 1986 Jul 30;379(1):104–111. [PubMed]
  • Feeney DM, Hovda DA. Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Res. 1985 Sep 9;342(2):352–356. [PubMed]
  • Hovda DA, Sutton RL, Feeney DM. Amphetamine-induced recovery of visual cliff performance after bilateral visual cortex ablation in cats: measurements of depth perception thresholds. Behav Neurosci. 1989 Jun;103(3):574–584. [PubMed]
  • Hovda DA, Fenney DM. Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Res. 1984 Apr 30;298(2):358–361. [PubMed]
  • MEYER PM, HOREL JA, MEYER DR. Effects of dl-amphetamine upon placing responses in neodecorticate cats. J Comp Physiol Psychol. 1963 Apr;56:402–404. [PubMed]
  • Sutton RL, Hovda DA, Feeney DM. Amphetamine accelerates recovery of locomotor function following bilateral frontal cortex ablation in cats. Behav Neurosci. 1989 Aug;103(4):837–841. [PubMed]
  • Wiebers DO, Adams HP, Jr, Whisnant JP. Animal models of stroke: are they relevant to human disease? Stroke. 1990 Jan;21(1):1–3. [PubMed]
  • Hovda DA, Feeney DM. Haloperidol blocks amphetamine induced recovery of binocular depth perception after bilateral visual cortex ablation in cat. Proc West Pharmacol Soc. 1985;28:209–211. [PubMed]
  • Feeney DM, Westerberg VS. Norepinephrine and brain damage: alpha noradrenergic pharmacology alters functional recovery after cortical trauma. Can J Psychol. 1990 Jun;44(2):233–252. [PubMed]
  • Izzo KL, Sobel E, Demopoulos JT. Diabetic neuropathy: electrophysiologic abnormalities of distal lower extremity sensory nerves. Arch Phys Med Rehabil. 1986 Jan;67(1):7–11. [PubMed]
  • Brailowsky S, Knight RT, Blood K, Scabini D. gamma-Aminobutyric acid-induced potentiation of cortical hemiplegia. Brain Res. 1986 Jan 8;362(2):322–330. [PubMed]
  • Brailowsky S, Knight RT, Efron R. Phenytoin increases the severity of cortical hemiplegia in rats. Brain Res. 1986 Jun 18;376(1):71–77. [PubMed]
  • Chweh AY, Swinyard EA, Wolf HH. Involvement of a GABAergic mechanism in the pharmacologic action of phenytoin. Pharmacol Biochem Behav. 1986 May;24(5):1301–1304. [PubMed]
  • Hernandez TD, Holling LC. Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Res. 1994 Jan 28;635(1-2):300–306. [PubMed]
  • Crisostomo EA, Duncan PW, Propst M, Dawson DV, Davis JN. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann Neurol. 1988 Jan;23(1):94–97. [PubMed]
  • van Woerkom TC, Minderhoud JM, Gottschal T, Nicolai G. Neurotransmitters in the treatment of patients with severe head injuries. Eur Neurol. 1982;21(4):227–234. [PubMed]
  • Evans RW, Gualtieri CT, Patterson D. Treatment of chronic closed head injury with psychostimulant drugs: a controlled case study and an appropriate evaluation procedure. J Nerv Ment Dis. 1987 Feb;175(2):106–110. [PubMed]
  • Dikmen SS, Temkin NR, Miller B, Machamer J, Winn HR. Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA. 1991 Mar 13;265(10):1271–1277. [PubMed]
  • Goldstein LB, Davis JN. Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease. Neurology. 1988 Nov;38(11):1806–1809. [PubMed]
  • Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975 Mar 1;1(7905):480–484. [PubMed]
  • Smith KR, Jr, Goulding PM, Wilderman D, Goldfader PR, Holterman-Hommes P, Wei F. Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Arch Neurol. 1994 Jul;51(7):653–660. [PubMed]
  • Rao N, Jellinek HM, Woolston DC. Agitation in closed head injury: haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil. 1985 Jan;66(1):30–34. [PubMed]
  • Lipper S, Tuchman MM. Treatment of chronic post-traumatic organic brain syndrome with dextroamphetamine: first reported case. J Nerv Ment Dis. 1976 May;162(5):366–371. [PubMed]
  • Gualtieri T, Chandler M, Coons TB, Brown LT. Amantadine: a new clinical profile for traumatic brain injury. Clin Neuropharmacol. 1989 Aug;12(4):258–270. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group